Adamax: Which Molecule Was Actually Tested?
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

When Adamax is discussed alongside Semax, start with a simple question: which molecule did the researchers actually test? A related name is not enough. For this explainer, a directly verified primary study of the peptide called Adamax was not located. That is a research limitation, not proof that none exists. A frequently cited rat study measured BDNF-related changes after Semax. Those findings belong to Semax, and cannot establish Adamax effects, brain delivery or duration. Before making a stronger claim, verify the structure, analytical identity and studies of that exact compound. Until then, claims of enhanced potency or safety remain unsupported here.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Dolotov et al. (2006): Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
https://pubmed.ncbi.nlm.nih.gov/16996037/
Primary Semax rat study, not an Adamax study

[2] FDA: Semax-related bulk drug substances briefing for July 23-24, 2026 PCAC meeting
https://www.fda.gov/media/193348/download
Official assessment of Semax-related substances, not Adamax

EVIDENCE LIMITATIONS
The targeted search found no directly verified primary peptide study; direct PubMed query-page retrieval was unavailable. Do not present a definitive zero-results database audit.
No canonical Adamax sequence, adamantane modification, half-life, potency or brain-exposure claim is asserted.
A Semax study is not an Adamax study.
The first two scenes disclose this review scope; the cited Semax paper does not establish the absence of Adamax research.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
Original topic requested by Nina; not attributed to an additional verified Facebook video.